PHEAST THERAPEUTICS
Live / Applied — Statement of use — non-final action mailed (as of 11 Feb 2026)
What this means for you
Not registered yet, but its 04 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97295190
- Mark type
- Stylized text
- Filed
- 04 Mar 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer
Owner
- Pheast Therapeutics, Inc., Redwood City, CA, US
- Pheast Therapeutics, Inc., Palo Alto, CA, US
Prosecution history
- 11 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Feb 2026 — NON-FINAL ACTION E-MAILED
- 11 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 14 Jan 2026 — DATA MODIFICATION COMPLETED
- 14 Jan 2026 — ASSIGNED TO LIE
- 02 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jun 2025 — USE AMENDMENT FILED
- 02 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 05 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 4 GRANTED
- 19 May 2025 — SOU EXTENSION 4 FILED